Abstract:Background: The induction of CD4(+)CD25(+)Foxp3(+) Treg from CD4(+)CD25(-) T cells is deficient in the patients with systemic lupus erythematosus (SLE). Whether the induced CD4(+)CD25(+)Foxp3(+) Tregs possess defective function remains unclear. The purpose of the present research was to study the expression differences of functional membrane molecule between SLE patients and healthy controls by the induced CD4(+)CD25(+)Foxp3(+) Treg, in order to achieve a better understanding for the function deficiency of Treg in SLE. Methods: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors and SLE patients were used to separated CD4(+)CD25(-) T cells. These CD4(+)CD25(-) T cells were induced to differentiate into CD4(+)CD25(+)Foxp3(+) Tregs through incubating with CD3 and CD28 antibodies, TGF-beta, IL-2 and rapamycin in vitro. Flow cytometry was applied to analyze the expressions of PD-1, PD-L1, CTLA-4, mTGF-beta, LAP, CD39, mIL-10 and cIL-10, by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs. Results: (1) The induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs of both healthy controls and SLE patients both highly expressed PD-1. Nevertheless, the expressions of PD-L1 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were significantly lower than those in healthy controls, which were negatively correlated with SLEDAI; (2) The expressions of CTLA-4 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were also significantly reduced as compared with those in healthy controls, which were negatively correlated with SLEDAI; (3) As compared with healthy controls, the expressions of mTGF-beta by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs were also reduced in SLE patients, but there was no significant difference between active and inactive patients. While the expressions of LAP between SLE patients and healthy controls did not show significant difference; (4) The expressions of CD39 and mIL-10 displayed scarce significant differences between healthy controls and SLE patients, while the expressions of cIL-10 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were significantly increased, which were not correlated with SLEDAI. Conclusion: There were deficiencies in the expressions of PD-L1 and CTLA-4 in the induced CD4(+)CD25(+)Foxp3(+) Treg of SLE patients, which might be associated with the defective development and function of Treg involved in the pathological process of SLE.

IL-1β synergistically strengthen the LPS-induced dysfunction of B cells from SLE mice by up-regulation of TLR4 expression

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

The modulation of B cells survival and secretion of antibodies by interleukin-17-producing T cells in patients with systemic lupus erythematosus

Decreased CD1d level is associated with CD86 over-expression in B cells from systemic lupus erythematosus.

Ligation of CD180 Inhibits IFN-α Signaling in a Lyn-PI3K-BTK-dependent Manner in B Cells

Tlr9-Induced Mir-155 And Ets-1 Decrease Expression Of Cd1d On B Cells In Sle

Role of Transcription Factor ETS-1 and B Cell in the Pathogenesis of Systemic Lupus Erythematosus

Increased Interleukin 21 and Follicular Helper T-like Cells and Reduced Interleukin 10+ B Cells in Patients with New-onset Systemic Lupus Erythematosus

Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus

LSO-002 the Transcriptional Factor Pbx1 Adjusts Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity

TLR-Induced SMPD3 Defects Enhance Inflammatory Response of B Cell and Macrophage in the Pathogenesis of SLE

Anti-IL-12/23 P40 Antibody Attenuates Chronic Graft-Versus-host Disease with Lupus Nephritis Via Inhibiting Tfh Cell in Mice

Low expressions of PD-L1 and CTLA-4 by induced CD4<SUP>+</SUP>CD25<SUP>+</SUP> Foxp3<SUP>+</SUP> Tregs in patients with SLE and their correlation with the disease activity

Up-regulation of proBDNF/p75 NTR signaling in antibody-secreting cells drives systemic lupus erythematosus

Commentary: Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus

Involvement of type Ⅰ interferon in modulating activation and TLRs expression on T cells in systemic lupus erythematosus

Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus